General MedicationsINJECTIONStandard
ONDANSETRON
ONDANSETRON
Standard Dose
4MG/2ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ONDANSETRON is listed in Drugs@FDA under application 079032 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON Form and strength INJECTABLE; INJECTION - 4MG/2ML Sponsor AM REGENT Submission history Latest submission status date: 2015-01-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview ONDANSETRON is listed in Drugs@FDA under application 079032 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON Form and strength INJECTABLE; INJECTION - 4MG/2ML Sponsor AM REGENT Submission history Latest submission status date: 2015-01-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.